Prosecution Insights
Last updated: November 20, 2026
Application No. 18/119,785

SELF CENTERING LOW FRICTION EXTENDABLE CATHETER

Non-Final OA §102
Filed
Mar 09, 2023
Priority
Sep 14, 2020 — provisional 63/078,143 +1 more
Examiner
STIMPERT, PHILIP EARL
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Imperative Care Inc.
OA Round
3 (Non-Final)
63%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
571 granted / 902 resolved
-6.7% vs TC avg
Strong +49% interview lift
Without
With
+48.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
53 currently pending
Career history
970
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
49.3%
+9.3% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
28.5%
-11.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 902 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 8 October 2026 has been entered. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-9 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by U.S. Patent 4,954,129 to Giuliani et al. (Giuliani hereinafter). Regarding claim 1, Giuliani teaches an extendable catheter (see Fig. 1) having an outer catheter (14) with a proximal end (at 34), a distal end (62), and a sidewall (66), defining a central lumen, and a longitudinal axis, an inner extension segment (16) with a proximal end (at 34), a distal end (36) and being extended (and therefore extendable) through the central lumen. Giuliani further teaches a plurality of projections (64 or 70) positioned in the central lumen in an annular gap between the segment and the outer catheter, the projections configured to center the extension segment in the central lumen (col. 4, ln. 10-23, “centralize the probe 16”) wherein the projections are surrounded by the inner surface of the central lumen. Regarding claim 2, Giuliani teaches eight projections, which is greater than the required three. Regarding claim 3, Giuliani teaches the eight projections on the extension segment as well as further projections (see at 14 in Fig. 1) totaling more than ten such. Regarding claim 4, Giuliani teaches that the projections are carried on the outer surface of the inner extension segment (see Fig. 2). Regarding claim 5, Giuliani teaches an axially movable control wire (16). Regarding claim 6, Giuliani teaches a plurality of projections (70) arranged in a circumferential pattern. Regarding claim 7, Giuliani teaches that the centering feature includes rounded edges (see Fig. 2) in which various angles of inclination are defined which are not perpendicular to the longitudinal axis. Regarding claim 8, Giuliani teaches a primary catheter (14) and an extension segment (16, 38) with an exposed section shorter than the catheter (14), and a control wire (16) which produces axial movement of the extension segment (see col. 3, ln. 18-23, “the probe 16 is advanced through the catheter”). Giuliani further teaches a plurality of projections (64 or 70) positioned in the central lumen in an annular gap between the segment and the outer catheter, the projections configured to center the extension segment in the central lumen (col. 4, ln. 10-23, “centralize the probe 16”) wherein the projections are surrounded by the inner surface of the central lumen. Regarding claim 9, Giuliani teaches radially extending ridges (ribs 64). Response to Arguments Applicant’s arguments, see page 4, filed 8 October 2026, with respect to the rejection(s) of claim(s) under 35 U.S.C. 102 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Giuliani as discussed above. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US Pre-Grant Publication 2022/0111175 (Mitchell et al.) teaches another catheter having centering projections (see especially Figs. 19-20, ribs 652). Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP E STIMPERT whose telephone number is (571)270-1890. The examiner can normally be reached Monday-Friday, 8a-4p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHILIP E STIMPERT/Primary Examiner, Art Unit 3783 9 November 2026
Read full office action

Prosecution Timeline

Mar 09, 2023
Application Filed
Nov 07, 2023
Response after Non-Final Action
Oct 01, 2025
Non-Final Rejection mailed — §102
Mar 31, 2026
Response Filed
Jun 08, 2026
Final Rejection mailed — §102
Oct 08, 2026
Request for Continued Examination
Oct 23, 2026
Response after Non-Final Action
Nov 13, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788436
DEVICES AND METHODS FOR LAPAROSCOPIC ACCESS AND WOUND CLOSURE
3y 11m to grant Granted Nov 10, 2026
Patent 12779105
FLUID MANAGEMENT SYSTEM
4y 5m to grant Granted Nov 03, 2026
Patent 12766305
CLAMP
4y 0m to grant Granted Oct 20, 2026
Patent 12766259
BLOOD GLUCOSE CONTROL SYSTEM AND METHOD
3y 7m to grant Granted Oct 20, 2026
Patent 12752050
INFUSION PUMP
3y 9m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
63%
Grant Probability
99%
With Interview (+48.8%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 902 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month